1. Home
  2. Analysis
  3. Teveten
  4. Forteo

Teveten and Forteo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Teveten (eprosartan mesylate) and Forteo (teriparatide recombinant human). Common drug interactions include abdominal pain among females.

The phase IV clinical study analyzes what interactions people have when they take Teveten and Forteo. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Teveten?

Teveten has active ingredients of eprosartan mesylate. It is often used in high blood pressure. eHealthMe is studying from 1,482 Teveten users. Check the latest studies of Teveten.

What is Forteo?

Forteo has active ingredients of teriparatide recombinant human. It is often used in osteoporosis. eHealthMe is studying from 127,076 Forteo users. Check the latest studies of Forteo.

On Jul, 06, 2026

14 people who take Teveten and Forteo together, and have interactions are studied.

Teveten and Forteo drug interactions.

What are the common drug interactions of Teveten and Forteo, by gender? *:

female:

  1. Abdominal pain
  2. Asthenia (weakness)
  3. Dysuria (painful or difficult urination)
  4. Pallor
  5. Post procedural complication
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Body temperature increased
  9. Blood calcium increased
  10. Constipation

male:

n/a

What are the common drug interactions of Teveten and Forteo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Abdominal pain
  2. Asthenia (weakness)
  3. Dysuria (painful or difficult urination)
  4. Pallor
  5. Post procedural complication
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Body temperature increased
  9. Blood calcium increased
  10. Constipation

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 4 people, 28.57%
  2. Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 3 people, 21.43%
  3. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 14.29%
  4. Thyroid Diseases: 1 person, 7.14%
  5. Pain: 1 person, 7.14%
  6. Multiple Allergies (allergy to multiple agents): 1 person, 7.14%
  7. Diabetes: 1 person, 7.14%
  8. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 7.14%
  9. Cardiac Failure: 1 person, 7.14%
  10. Asthma: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Teveten and Forteo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Teveten and Forteo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Teveten:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Forteo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Teveten and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Forteo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on eprosartan mesylate and teriparatide recombinant human (the active ingredients of Teveten and Forteo, respectively), and Teveten and Forteo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.